1 / 5

European Geriatric Medicine Market Size, Competitive Analysis, Share, Forecast- 2020-2026

European Geriatric Medicine Market Size, Competitive Analysis, Share, Forecast- 2020-2026

preeti18
Download Presentation

European Geriatric Medicine Market Size, Competitive Analysis, Share, Forecast- 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research European Geriatric Medicine Market Size, Competitive Analysis, Share, Forecast- 2020-2026 Request a Free Sample @ https://www.omrglobal.com/request-sample/europe-geriatric- medicine-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The European geriatric medicine market is projected to witness considerable growth of 5.4% during the forecast period. The major factors contributing to the growth of the market include the increasing geriatric population in the Western European economies, such as Italy. Moreover, the high spending on healthcare facilities with the significant presence of key market players are other factors propelling the market growth in the region. UK has one of the most developed healthcare infrastructures for elderly people, owing to which, the market is growing at a considerable rate in the European region. Get Free Sample Copy @https://www.omrglobal.com/request-sample/europe-geriatric- medicine-market The geriatric medicine market is classified on the basis of therapeutics and conditions. Based on therapeutics, the market is segmented into analgesic, anticoagulant, antihypertensive, antidiabetic, and others. Based on the condition, the market is segregated into CVDs, diabetes, neurological, cancer, respiratory, and others. Among these conditions, the CVDs segment contributes significantly to the market. The significant contribution of the segment is backed by the significant patient pool of CVDs across the globe. With the rise in age, the development of CVDs increases subsequently. Therefore, a huge market is covered by CVDs medicines in the geriatric medicine market. Browse for Full Report Description@https://www.omrglobal.com/industry-reports/europe- geriatric-medicine-market Geographically, the European geriatric medicine market is segmented into Germany, UK, France, Italy, Spain, and the rest of Europe. UK contributed a significant share in the European geriatric medicine market. The growth is owing to the various healthcare facilities and well- developed healthcare infrastructure for the geriatric population. Further, Germany and France have a world-class healthcare system providing a stable platform for the growth of the geriatric medicine market in the respective countries. Apart from the major European countries, Switzerland, the Netherlands, Denmark, Norway Ireland, Hungary, and Belgium are some other countries of Europe that are providing a significant contribution to the growth of the geriatric medicine market in the region.

  3. The European geriatric medicine market is influenced by product development and advancements conducted by the market players. Some of the global key players of the geriatric medicine market include Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Merck & Co. Inc., Sanofi SA, Pfizer Inc., Johnson & Johnson Services Inc., and AstraZeneca PLC. These players are playing a significant role in the growth of the geriatric medicine market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others. Market Segmentation European Geriatric Medicine Market by Therapeutic Analgesic Anticoagulant Antihypertensive Antidiabetic Others (Statins and Antipsychotic) European Geriatric Medicine Market by Condition Cardiovascular Diseases (CVDs) Diabetes Neurological Cancer Respiratory Others (Arthritis and Osteoporosis) Regional Analysis UK Germany France Spain

  4. Italy Rest of Europe Company Profiles Abbott Laboratories Inc. Overview Abbott Laboratories in Europe Abbott Laboratories in Geriatric Medicine Landscape Recent Developments Amgen Inc. Astellas Pharma Inc. AstraZeneca PLC Boehringer Ingelheim GmbH Bristol-Myers Squibb Co. Cipla Ltd. Eli Lilly and Co. GlaxoSmithKline PLC Johnson & Johnson Services Inc. Merck & Co., Inc. Novartis AG Pfizer Inc. Sanofi SA Teva Pharmaceutical Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-geriatric-medicine-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and

  5. consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related